أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

Pension-fund rebalancing and other red flags that suggest a stock-market pullback is nearing, according to Goldman Sachs

An uneven rally is just one reason why the Goldman Sachs trading desk is bracing for a pullback after the …

This bank CEO let his AI clone handle an earnings call — now he's signing an OpenAI deal

It's part of Customers Bank CEO Sam Sidhu's effort to get ahead in the industry's race to transform itself using …

The bullish signals ahead of this week's Mag-7 earnings

Calls are trading more expensive than puts in the five names that report this week, and call volume outpaces put …

Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction

America's largest automakers are set to report first-quarter earnings results this week.

The SEC fears we’re trapped in short-term thinking. Tesla and Amazon prove investors play the long game.

Semiannual earnings reporting tries to “fix” a problem that the market’s success stories have already solved.

United Airlines CEO confirms he approached American Airlines about merger

United CEO Scott Kirby said American rejected the idea, "and without a willing partner, something this big simply can't get …

MAHA is mad. Its alliance with Trump is about to face its biggest test

Supreme Court arguments Monday and the farm bill put MAHA squarely at odds with President Donald Trump and the majority …

‘We believe it’s real’: My mom received a check from a class-action lawsuit. It bounced. Could this be a scam?

“Now they are deducting that amount from her account.”

Pullbacks will be shallow as market risks diminish, says Morgan Stanley

Earnings, capex and AI adoption are developing momentum and reducing opportunities for investors to buy into geopolitically-driven weakness

Verizon’s stock rises as the company posts surprise subscriber growth under new CEO

Earnings per share topped expectations, while revenue came up short.

A new version of an old drug is helping men grow back some of their hair

A safer — and more effective — formulation of the most popular hair-loss treatment led to robust hair growth in …

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone …